Tyromycin A
Tyromycin A is an inhibitor targeting Leu-AP, Cys-AP and CP-A, with an IC50 value of 25-41 μg/mL against porcine Leu-AP and an IC50 value of 60 μg/mL against bovine CP-A. Tyromycin A inhibits the hydrolytic activity of target peptidases and exhibits selective activity against Gram-positive bacteria. Tyromycin A moderately inhibits the infectivity of HCV in human hepatocytes, with an IC50 of 6.6 μM, and its inhibitory activity depends on the two maleic anhydride domains. Tyromycin A can be used in studies related to Gram-positive bacterial infections and hepatitis C virus infections.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 141364-77-4
- Formel: C26H38O6
- Molecular Weight:446.58
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
|
HCV 6.6 μM (IC50) |
Leu-AP 25-41 μg/mL (IC50) |
CP-A 60 μg/mL (IC50) |
Tyromycin A (30 min) inhibits leucine aminopeptidase bound to the surface of HeLa S3 cells with a Ki value of 4×10-5 M; it also inhibits cysteine aminopeptidase with a Ki value of 1.3×10-5 M[1].
Tyromycin A inhibits porcine kidney cytosolic leucine aminopeptidase (IC50 25-31 μg/mL), porcine kidney microsomal leucine aminopeptidase (IC50 27-41 μg/mL), and bovine pancreatic carboxypeptidase A (IC50 60 μg/mL) in cell-free assays[1].
Tyromycin A (30 min) weakly inhibits leucine aminopeptidase activity in HeLa (KB3.1) cells, with an IC50 greater than 150 μg/mL at both 50 μM and 100 μM L-Leu-AMC substrate concentrations[2].
Tyromycin A (30 min) weakly inhibits leucine aminopeptidase activity in HeLa (KB3.1) cells, with an IC50 >150 μg/mL at both 50 μM and 100 μM L-Leu-AMC substrate concentrations[2].
Tyromycin A selectively inhibits the growth of Gram-positive bacteria, with the strongest inhibitory activity against *Bacillus subtilis* DSM10 (MIC = 9.375 μg/mL), and shows no activity against the tested Gram-negative bacteria or fungi[2].
Tyromycin A exhibits selective activity against Gram-positive bacteria, with the strongest potency against *Bacillus subtilis* DSM10 (MIC = 9.375 μg/mL), and shows no activity against Gram-negative bacteria or fungi[2].
Tyromycin A (40 μM; 3 days) moderately inhibits HCV infectivity in Huh-7.5 human hepatocytes, with an IC50 of 6.6 μM[2].
Tyromycin A (100 μg/mL) shows no significant nematicidal activity against *Caenorhabditis elegans*[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 141364-77-4
-
Molecular Weight 446.58
-
Formel C26H38O6
-
SMILES
O=C1OC(C(CCCCCCCCCCCCCCCCC(C(O2)=O)=C(C)C2=O)=C1C)=O
-
Structure Classification
-
Initial Source
from the Kenyan WoodInhabiting Basidiomycete, Skeletocutis sp.
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
[1]. Weber W, et al. Tyromycin A: a novel inhibitor of leucine and cysteine aminopeptidases from Tyromyces lacteus. Planta Med. 1992 Feb;58(1):56-9. [Content Brief]
[2]. Chepkirui C, et al. Skeletocutins A-L: Antibacterial Agents from the Kenyan Wood-Inhabiting Basidiomycete, Skeletocutis sp. J Agric Food Chem. 2019 Aug 7;67(31):8468-8475. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Tyromycin A Related Classifications
HY-N19639 Related Classifications
Powered by Bioz